Key result
Elevated T-wave amplitude variability linked to ~151% higher risk of mortality and ventricular tachyarrhythmias.
Why the study?
T-wave amplitude variability has been proposed as a risk marker for adverse cardiovascular outcomes, but its prognostic value remains unclear.
Does elevated T-wave amplitude variability predict adverse cardiovascular outcomes?
Meta-Analysis (n=1,366)
Does elevated T-wave amplitude variability predict adverse cardiovascular outcomes?
Elevated T-wave amplitude variability is associated with an increased risk of adverse cardiovascular outcomes, supporting its potential utility for longitudinal risk stratification.
Background T‐wave amplitude variability (TAV), a marker of beat‐to‐beat ventricular repolarization instability, has been proposed as a potential risk marker for adverse cardiovascular outcomes, but its prognostic value remains unclear. Objectives This meta‐analysis aimed to quantitatively synthesize evidence on the association between elevated TAV and adverse cardiovascular outcomes. Methods A systematic literature search of PubMed, Embase, and the Cochrane Library was conducted. Observational studies reporting adjusted effect estimates for the association between TAV and adverse cardiovascular outcomes were included, and separate meta‐analyzes were conducted according to effect measures (hazard ratios [HRs] or odds ratios [ORs]) and exposure definition. Effect estimates were pooled using a random‐effects model. Statistical heterogeneity was assessed using the Q statistic and I 2 . Results Seven studies involving 1366 patients were included. HR‐based analyzes ( n = 3) showed that elevated TAV was significantly associated with an increased risk of adverse outcomes, including mortality and ventricular tachyarrhythmias (pooled HR 2.51, 95% CI 1.57–4.00; I 2 = 7%). In contrast, OR‐based analyzes showed no statistically significant association between TAV and ventricular tachyarrhythmias, whether evaluated as categorical (high vs. low TAV: pooled OR 3.82, 95% CI 0.87–16.84; I 2 = 75%) or continuous variable (per 1–μV increase: pooled OR 1.11, 95% CI 0.94–1.30; I 2 = 70%). Conclusion Elevated TAV is associated with an increased risk of adverse cardiovascular outcomes in HR‐based analyzes, supporting its potential utility as a marker of repolarization instability for longitudinal risk stratification. In contrast, its association with ventricular tachyarrhythmias was not significant in OR‐based analyzes, which showed substantial heterogeneity. Trial Registration: PROSPERO: CRD420251171782.
No takes yet. Share an insight, caveat, or question.
Sobue et al. (2026) conducted a meta-analysis in Cardiovascular disease risk (n=1,366). Elevated T-wave amplitude variability vs. Low T-wave amplitude variability was evaluated on Adverse outcomes, including mortality and ventricular tachyarrhythmias (HR 2.51, 95% CI 1.57-4.00). Elevated T-wave amplitude variability was associated with an increased risk of adverse cardiovascular outcomes, including mortality and ventricular tachyarrhythmias (HR 2.51; 95% CI 1.57-4.00).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: